Skip to main content
Livermore
Livermore
ZHEN

Vaughan & Co Securities, Inc.

SEC CIK
0000805870
Latest filing
Aug 3, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Vaughan & Co Securities, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,622
Value
$659.8K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Vaughan & Co Securities, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,622$659.8K0.3%−119−4.3%ReducedHolders
Q1 20262,741$596.1K0.3%−59−2.1%ReducedHolders
Q4 20252,800$639.8K0.3%−137−4.7%ReducedHolders
Q3 20252,937$680.0K0.4%−588−16.7%ReducedHolders
Q2 20253,525$654.3K0.4%−6−0.2%ReducedHolders
Q1 20253,531$739.8K0.5%−57−1.6%ReducedHolders
Q4 20243,588$637.6K0.4%−14−0.4%ReducedHolders
Q3 20243,602$711.3K0.4%−13−0.4%ReducedHolders
Q2 20243,615$620.0K0.4%+38+1.1%AddedHolders
Q1 20243,577$651.4K0.4%−390−9.8%ReducedHolders
Q4 20233,967$614.8K0.4%−87−2.1%ReducedHolders
Q3 20234,054$604.3K0.4%−15−0.4%ReducedHolders
Q2 20234,069$548.2K0.4%−20−0.5%ReducedHolders
Q1 20234,089$651.7K0.5%−1,008−19.8%ReducedHolders
Q4 20225,097$823.7K0.7%−197−3.7%ReducedHolders
Q3 20225,294$711.0K0.6%−74−1.4%ReducedHolders
Q2 20225,368$822.0K0.7%00.0%UnchangedHolders
Q1 20225,368$870.0K0.6%−59−1.1%ReducedHolders
Q4 20215,427$735.0K0.5%00.0%UnchangedHolders
Q3 20215,427$585.0K0.4%00.0%UnchangedHolders
Q2 20215,427$611.0K0.5%00.0%UnchangedHolders
Q1 20215,427$587.0K0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.